Loading company…
T3 Pharmaceuticals AG is a Swiss biopharmaceutical company developing therapies for oncology and immuno-oncology.
Founded in 2015 and headquartered in Allschwil, Switzerland, T3 Pharmaceuticals AG develops biopharmaceutical therapies for oncology and immuno-oncology. The company was co-founded by Christoph Kasper, Marlise Amstutz and Simon Ittig, and Simon Ittig is CEO. On July 22, 2020, it raised CHF 25 million from investors including Boehringer Ingelheim Venture, Reference Capital Management and Wille Finance, bringing its total funding to CHF 450 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in